Market Overview

Trade GSK stock with recommended broker Ally Invest. Commissions as low as $3.95.

Analyst Rating View All Ratings

DateResearch FirmActionCurrentTarget
8/20/18ArgusMaintainsBuyBuy47.0
10/26/17Bank of AmericaDowngradesBuyNeutral
7/05/17CitigroupDowngradesBuyNeutral
Show more Loading articles...
Show more Loading articles...

Earnings View Earnings

Q2 2018 EST Actual Surprise
EPS: 0.78 0.38 -0.4
Rev: 9.70B 9.87B 169.00M
Q3 2018 EST Actual Surprise
EPS: Expected
2018-10-31
Rev:

Company Profile